Scientists defy expectations, drive entrepreneurship in cancer research commercialization.
Scientists have found that the Bayh-Dole Act may not accurately measure how many university scientists start new businesses. They created a new way to measure scientist entrepreneurship based on their commercial activities. By studying scientists funded by the National Cancer Institute, they discovered that scientists are more likely to start their own businesses than previously thought. This shows that scientist entrepreneurship is more common than what was previously believed based on traditional data sources.